Strong sales growth and gross margin expansion Reig''s H1 numbers grew 19% vs last year, with double-digit growth in all divisions. Pharma Technologies (+14%) is progressively increasing the utilisation capacity in the Barcelona facility. Specialty pharma grew 31%, with strong numbers from osteoarticular activity thanks to the new subsidiary in Poland and the agreement with Stada group. Finally, Consumer Healthcare maintains growth (14%), thanks to respiratory and earcare. Although inflation has ....